PQQ
Research Reliability -
A potent antioxidant and mitochondrial biogenesis activator that supports cognitive health, energy production, and cellular longevity.
Appetite
Mood
Sleep
PQQ
Description
Pyrroloquinoline quinone (PQQ) is a novel redox cofactor found in small amounts in plant foods that activates CREB and PGC-1alpha, transcription factors that stimulate the growth of new mitochondria in a process known as mitochondrial biogenesis. This makes PQQ unique among supplements in its ability to actually increase the number of mitochondria in cells, not just support their function. It also functions as a potent antioxidant capable of cycling thousands of times without becoming depleted. Research supports benefits for memory, cognitive function, inflammation reduction, and energy levels, particularly when combined with CoQ10.
Effects
First 2 weeks
subtle
Weeks 4–8
energy and mental stamina may improve
Ongoing
mitochondrial support, pairs with CoQ10
How it Feels
Gentle and gradual; some people notice steadier energy and clearer thinking over a month, others little. It works on mitochondrial density, which is inherently a slow process. Commonly stacked with CoQ10.
Usage
Entry Dose
10mg
Standard Dose
20mg
Max Dose
40mg
Onset
4–8 weeks (mitochondrial)
Combinations
Pairs well with
Synergistic
CoQ10 — PQQ stimulates new mitochondria; CoQ10 powers the ones you already have
Ribose-C — PQQ upregulates mitochondrial biogenesis; ribose fuels ATP synthesis inside
Niacinamide (NAD+ precursor) — NAD+ and PQQ operate in the same mitochondrial electron transport context
Avoid combining
Contraindicated
No established contraindications — well-tolerated at standard doses; limited long-term human data
Chemotherapy — antioxidant activity may theoretically interfere; consult oncologist
Biomarkers to Track
Subjective
(Daily)
Energy and mental clarity (1–10)
Exercise endurance score
Sleep quality score
Objective
(Quarterly)
Plasma PQQ level (specialty)
HRV baseline score
NGF levels (specialty test)
Generally safe in studied doses.
Pregnant and breastfeeding women, due to limited data.
Expecting fast results, when mitochondrial changes are slow.
Preliminary (limited / small human data)
Mitochondrial biogenesis claims are based substantially on animal data; human trials are few and small.
Nakano M et al. (2012). Journal of Clinical Biochemistry and Nutrition. Human study (PQQ supplementation and cognitive function). PMID: 22798713.